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Abstract
We reviewed the literature to determine the effectiveness of HIV-related interventions in reducing
HIV/AIDS stigma. Studies selected had randomized controlled trial (RCT), pretest–posttest with a
non-randomized control group, or pretest–posttest one group study designs in which HIV-related
interventions were being evaluated, and in which HIV/AIDS stigma was one of the outcomes
being measured. A checklist was used to extract data from accepted studies, assess their internal
validity, and overall quality. Data were extracted from 19 studies, and 14 of these studies
demonstrated effectiveness in reducing HIV/ AIDS stigma. Only 2 of these 14 effective studies
were considered good studies, based on quality, the extent to which the intervention focused on
reducing HIV/AIDS stigma, and the statistics reported to demonstrate effectiveness. Future studies
to reduce HIV/AIDS stigma could improve by designing interventions that pay greater attention to
internal validity, use validated HIV/AIDS stigma instruments, and achieve both statistical and
public health significance.
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Stigma originally was defined as “a dynamic process of devaluation that ‘significantly
discredits’ an individual in the eyes of others” [1]. Since Goffman’s seminal work, research
on stigma has explored negative social attitudes (perceived stigma), and discriminating
behaviors (enacted stigma) toward stigmatized individuals [2,3]. Self-stigma (or internalized
stigma) has also been examined, which results from fear of enacted stigma [4]. Some
examples of self-stigma include individuals hiding their diagnoses or socially isolating
themselves from others, or feeling ashamed of having a particular disease/condition.
The scientific literature on stigma has expanded considerably in the era of HIV/AIDS, given
that having HIV disease is viewed more negatively than many other stigmatized conditions,
such as mental illness and other physical health problems [5,6]. Conceptually, we know that
HIV/AIDS stigma is multi-layered or compounded with already marginalized behaviors,
such as sex work, drug use, and homosexual sexual practices; and vulnerable groups, such as
prisoners or migrant populations [7]. We are also more aware of the many underlying factors
at the community or social levels that may be causing HIV/AIDS stigma to surface,
including lack of knowledge or understanding about the illness; misconceptions about how
HIV is transmitted; lack of access to treatment; how media shapes the reporting on the
epidemic; the incurability of AIDS; and existing prejudice and fear toward specific groups
[7–9]. Furthermore, the concepts of perceived, enacted, internalized, and/or compounded
stigma have been advanced by the development of quantitative measurements (some of them
validated) to assess the types of stigma persons living with HIV/AIDS (PLWHA) are feeling
or experiencing, or to assess non HIV-infected individuals’ perceived or enacted stigma
towards PLWHA [10]. Lastly, a large body of research suggests that HIV/ AIDS stigma is a
barrier associated with disclosure and negative health outcomes, impacting HIV preventive
behaviors [8]; HIV care-seeking behaviors [11,12]; quality of care for PLWHA [11–13]; and
treatment of PLWHA among loved ones [14] health care providers [12], and the larger
community [8,9,15]. The negative health outcomes resulting from HIV/AIDS stigma have
made it necessary for HIV prevention and treatment programs to focus greater efforts on
reducing HIV/AIDS stigma.
Despite its negative impact on PLWHA, there surprisingly have been a limited number of
intervention studies aimed at reducing HIV/AIDS stigma. What have been published, to
date, are two reviews that summarize interventions with stigma reduction components
[16,17], and one conceptual article describing what we can learn from HIV/AIDS stigma
reduction interventions [9]. The 2003 review is the most relevant because of its focus on
HIV/ AIDS stigma [16]. This review identified 22 intervention studies that had HIV/AIDS
stigma reduction component(s), with the most common measurements of HIV/AIDS stigma
being perceived stigma of non-infected populations towards PLWHA, and stigma perceived
by PLWHA emanating from non-infected populations. In addition, this review provided a
useful categorization of intervention strategies commonly implemented to reduce HIV/AIDS
stigma. A second review was conducted on stigma reduction strategies for different diseases/
conditions [17]. Although it did not focus on HIV/ AIDS exclusively, this review was useful
because it described similar stigma reduction strategies targeted at the individual,
interpersonal, and community levels.
From these reviews, we have a better understanding of how HIV/AIDS stigma is being
measured in intervention studies, types of stigma reduction strategies being implemented,
and at which levels these stigma reduction strategies are being targeted. What is lacking
from these reviews, however, is a systematic review to determine the quality of these studies
vis-à-vis their effectiveness in reducing HIV/AIDS stigma. Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines indicate that quality, or the
Sengupta et al. Page 2













internal validity, should be assessed for each intervention study by examining the risk of
bias at the study design and outcome levels [18]. In reporting this information for a given
study, we can be more confident that the study’s estimate of effect is correct. Our goal in the
current systematic review is to update and expand upon the two prior reviews by broadening
our search for intervention studies that may or may not target HIV/AIDS stigma, but
measure HIV/AIDS stigma, pre-and post-intervention. This will potentially increase the pool
of HIV-related interventions found since there are not as many that solely target stigma
reduction. Another distinct feature of this review is that we will assess the risks of bias at the
study design and outcome levels by rating the quality of the intervention studies reviewed.
We will conclude by making recommendations on how to use this review to inform future
HIV-related research/programs that incorporate HIV/AIDS stigma reduction as one of their
objectives.
Methods
Search Strategy and Data Sources
To answer our research question, do populations that receive an HIV-related intervention
have lower levels of HIV/AIDS stigma at posttest assessment, compared to pretest
assessment?, our Population Intervention Comparison Outcome (PICO) search strategy [19]
included a combination of key words and/or MESH terms to maximize our ability to find
relevant articles (Supplemental Electronic Information 1).
With our last search occurring in March 2009, we identified published studies in the
electronic databases of PubMed, PsychInfo, CINAHL, Social Work Abstracts, Web of
Science (ISI), and the gray literature (unpublished research reports that are not found in
traditional peer-reviewed publications) electronic databases of Google Scholar and Aegis.
We also searched in NC Live, which is comprised of a number of databases, including gray
literature databases.
We did not restrict publication date or the study population in which the intervention took
place, but did limit the search to English-language articles and human populations.
Moreover, unlike the 2003 review [16], we did not restrict the intervention to include a
stigma reduction component in our search strategy, since our research question was
interested in whether or not there was a reduction in HIV/AIDS stigma regardless of the
HIV-related intervention used.
Study Selection
For the initial search, two reviewers independently reviewed the abstracts of studies to
accept or reject for full text review using our PICO search strategy. Abstracts were rejected
if the studies did not have (1) interventions that were HIV-related, (2) at least one
quantitative HIV/AIDS stigma outcome measure, and (3) a study design that had pre-/post-
intervention data collection time points. Any disagreements for which to accept or reject
were resolved by discussion, and referral to a third reviewer, if necessary. For studies that
were accepted at the abstract level, we did an ancestry search of their references to identify
other relevant studies [20].
Full Text Review and Data Extraction
The same two reviewers independently reviewed the full texts of the studies identified from
the electronic and ancestry searches to determine if they were still eligible to undergo data
extraction. Data were extracted from eligible studies into an electronic spreadsheet.
Reviewers met to reconcile any disagreements in the data extracted, and referral to third
reviewer was done to resolve any disputes.
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We extracted the following data: study characteristics (publication date, authors, study
objectives, study population, study location, duration of intervention, description of the
stigma measure, and the stigma outcome findings); type of study design; and intervention
characteristics (types of intervention strategies used, whether or not part or all of the
intervention focused on reducing HIV/AIDS stigma). To classify the intervention strategies,
we used Brown et al.’s [16] scheme that was divided into four types of intervention
strategies: (1) information–based approaches (e.g., written information in a brochure), (2)
skill building (e.g., hands-on learning strategies for resolving negative attitudes), (3)
counseling approaches (e.g., PLWHA support groups and resources), and (4) contact/
interaction with PLWHA (e.g., testimonials, interaction between PLWHA and the general
public).
In addition, we developed a checklist informed by a comparative effectiveness guide
developed by the Agency for Healthcare Research and Quality (AHRQ) to assess the
studies’ internal validity and overall quality [21]. For the randomized control trials (RCTs)
and pretest–posttest with non-randomized control group studies, we looked for any
information that was given about (1) if and how participants were randomized; (2) the extent
to which there was a risk for selection bias when comparing groups at baseline and loss to
follow-up; (3) possible risk of confounding bias if the groups were not comparable at
baseline, analysis was not intention-to-treat (ITT) (applicable for RCTs only), and/or
confounders (typically would be certain demographic that were not similar among groups,
but also could be other variables) were not adjusted for in the statistical analysis; and (4)
possible risk of measurement bias if an un-validated measure of stigma was used, and the
outcome assessor—the person or people who were responsible for analyzing the data–were
not blinded to the assignment or exposure group status. For the pretest–posttest one group
studies, we considered their internal validity inherently lowered because they do not have a
control group. We further assessed these studies’ internal validity by taking into
consideration loss to follow-up, if confounders were identified and adjusted for in the
statistical analysis, and whether or not a validated stigma measure was used. Using AHRQ’s
guidelines,[21] qualitative ratings of “good,” “fair,” or “poor” were given for each of these
internal validity indicators to indicate low risk of bias (good) to high risk of bias (poor). We
also rated for the extent to which the intervention focused on reducing HIV/AIDS stigma
(All components = good, 1 or more components = fair, None = poor), and the statistics used
and reported to demonstrate effectiveness (used statistics appropriately = good, did not use
statistics appropriately = poor). We rated the studies on all of these variables, and then
provided an overall quality rating of “good,” “fair,” or “poor,” with “good” indicating the
highest quality studies in this review (Supplemental Electronic Information 2).
Results
We selected 19 studies with HIV-related interventions that had an HIV/AIDS stigma
outcome to answer our research question, do populations that receive an HIV-related
intervention have lower levels of HIV/AIDS stigma at posttest assessment, compared to
pretest assessment? Following PRISMA guidelines [18], Fig. 1 illustrates our process for
selecting studies that were included in this systematic review.
Our initial search identified 515 abstracts. After reviewing these abstracts, only 35 studies
were accepted, based on our PICO search strategy. We performed an ancestry search of
these 35 studies’ references to identify any other relevant studies. The ancestry search
yielded 40 additional studies that we selected by their titles. We then full text reviewed the
35 studies from the electronic search, and the 40 studies from the ancestry search, to
determine if they were still eligible. Only 22 of these studies were still eligible after full text
review, and were selected for data extraction. The reason for rejecting the other 53 studies
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primarily was because they did not meet our study design criterion after reading their full
texts. Furthermore, during our data extraction, we discovered and rejected 3 of the 22 studies
that did not use paired data to appropriately evaluate pre- and post-intervention changes in
their HIV/AIDS stigma outcome. Thus, 19 studies were included in this systematic review,
seven of which were not part of Brown et al.’s [16] review given that they were published in
2004 or later. While the majority of the studies were published and found in one of the
electronic databases, one unpublished dissertation [22] was found in Proquest (one of the
databases covered in NC Live) and two published studies [23,24] were found through our
ancestry search.
Study and Intervention Characteristics
Table 1 (and Supplemental Electronic Information 3) summarizes the study and intervention
characteristics by study design for the 19 studies. [22–40] Nine of the studies were RCTs
[25–33], six were non-randomized control group study designs [24,34–38], and four were
pretest/ posttest without a control group study designs [22,23,39,40]. Of the 9 RCTs, six
were conducted in the United States or in other North American or European countries
[26,27,29–32], two in Asian countries [25,33], and one in an African country [28]. Four of
the RCTs focused on student populations [27–29,31], two focused on health care provider
populations [32,33], one was a community level intervention [25], and the remaining two
focused on families [30] and women [26]. Their interventions’ durations ranged from 15
minutes to 2 years. We then used Brown et al.’s classification of types of interventions to
categorize the intervention components [16]. All nine of the studies used informational
approaches to deliver their intervention. One of the studies used all four of the intervention
strategy categories (informational approaches, skill building, counseling/support, and
PLWHA testimonials) [25]. Two of the studies used 3 of the 4 strategies (informational
approaches, skill building, and PLWHA testimonials) [31,33].
Of the six non-randomized control group studies, three were conducted in African countries
[34,35,38], two were conducted in Asian countries [24,36], and one was conducted in a
European country [37]. Three of these studies focused on student populations [34,35,37],
one was conducted with health care providers [36], one was a community level intervention
[24], and the last focused on working women [38]. Their interventions’ duration ranged
from 3 days to 1 year. Like the RCTs, all six of the non-randomized control group studies
used informational approaches to deliver their intervention. One of the studies used three of
the strategies (informational approaches, skill building, and PLWHA testimonials) [36], and
two of the studies additionally used skill building [34] and support groups [24] along with
informational approaches to deliver their interventions.
For the four studies without a control group, three were conducted in the United States
[22,23,40], and one was conducted in India [39]. Three of the studies focused on health care
providers [22,39,40], and the fourth study focused on PLWHA [23]. Their interventions’
duration ranged from 1 hour to 3 years. All four of these studies used informational
approaches to deliver their intervention. Two of the studies additionally used counseling/
support groups to deliver their interventions [23,39]. One of the studies used all four of the
intervention strategies [39].
Description of Stigma Outcome Measures and Findings
Table 2 (and Supplemental Electronic Information 4) organizes the 19 studies by the extent
to which their interventions focus on stigma reduction, and for each study, presents the study
population(s) targeted, a brief description of the types of HIV/AIDS stigma measures used
(number of items, whether or not they were validated, and types of stigma measured), and
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the findings associated with the measures. Interestingly, none of the 19 studies used a
common measure to evaluate pre- and post-changes in HIV/AIDS stigma.
All 19 studies measured perceived stigma, mainly in the form of asking respondents to agree
or disagree on statements reflecting various attitudes toward PLWHA. Seven of these 19
studies also measured enacted stigma, mainly in the form of asking respondents whether
they agree or disagree with different discriminatory behaviors towards PLWHA
[24,25,30,33,35,36,39]. None of the 19 studies measured internalized or compounded
stigma.
Nine of the 19 studies used either a previously/originally developed and validated, multi-
item scale/index in which a summary or mean score was calculated, ranging from 4 to 30
items [22,23,25,27–30,32,38]. Of these nine studies, however, three did not provide a score
range and its interpretation for their measures to adequately assess if HIV/AIDS stigma was
reduced or had increased as a result of the intervention [22,27,32]. Two of the studies used
scales to measure stigma from the perspectives of PLWHA [23,25], and only one of these
studies measured stigma in both un-infected and PLWHA participants [25]. Of the nine
studies that used validated scales, seven studies reported a statistically significant post-
intervention change in their HIV/AIDS stigma outcome measure at P < .05 or lower
[23,25,27–30,38], but only 5 of these 7 studies convincingly demonstrated post-intervention
stigma reduction, based on their reported stigma outcome results [23,25,27,28,30]. The other
two studies that were statistically significant did not report the actual results (e.g., effect size
or score differences) [29], or obtain an effect size >1 for either the intervention or control
group [38].
Ten of the 19 studies measured HIV/AIDS stigma with originally developed and un-
validated individual items, not constituting a scale, with results reported for each individual
item. Six of the 10 studies measured HIV/AIDS stigma with 1–3 items [26,28,31,33,35,37],
and four studies with greater than four items [24,36,39,40]. For one of these studies with 12
items, score differences were not reported for its control group [24]. Only one of these
studies measured stigma in both un-infected and PLWHA participants [24]. Of the 10
studies that used individual items to measure HIV/AIDS sigma, six studies reported a
statistically significant post-intervention change in one or more of their HIV/AIDS stigma
items at P < .05 or lower [24,34–37,39]. For two of the studies, only 1 of 3 of their items
demonstrated reduced HIV/AIDS stigma post-intervention [35,37]. For the study that
measured 12 items, 11 of the 12 items demonstrated stigma reduction in the intervention
group, but these items’ pre/post-intervention differences were not reported for the control
group, making it difficult to evaluate this study based on its original study design (non-
randomized control group) [24].
Quality Assessment
In Table 3, we present the 19 studies’ quality assessment using the checklist in Supplemental
Electronic Information 2. The 19 studies were categorized by study design, and whether or
not they had a statistically significant reduction in their HIV/AIDS stigma outcome. None of
the 19 studies reported power calculations to determine if they had sufficient samples sizes
to assess effectiveness of their interventions.
RCTs’ Quality Ratings
Of the nine RCTs, five had a statistically significant reduction in their stigma outcome
measurement [25,27–30] (Table 3). Only 2 [25,33] of the 9 RCTs had interventions that
focused solely on reducing HIV/AIDS stigma. The majority of the nine RCTs did not
identify their method of randomization, nor if they concealed the order of assignments from
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investigators involved in these trials, and thus, were given “poor” ratings for these factors.
Ashworth [26]—a non-significant study—however, did mention a method of randomization,
and was given a “fair” rating on this factor.
Degree of selection bias relating to comparison of groups at baseline and loss to follow-up
varied in the RCTs. For the significant studies, Krauss [30] minimized selection bias by
demonstrating both similar baseline characteristics in groups and low differential loss to
follow-up. Apinundecha [25] also demonstrated similar baseline characteristics in groups,
but failed to report any information to evaluate if there was loss to follow-up, and thus, was
given a “poor” rating for this factor. For the non-significant studies, Wu [33] had “good”
ratings for selection bias, followed by Ashworth [26] that was given a “fair” rating for
similar baseline characteristics in groups since this study mentioned having similarities
without presenting a table to demonstrate these similarities.
Degree of confounding bias was rated based on if they stated that they used an Intention to
Treat (ITT) analysis (takes into account initial assignment and any loss to follow-up), and
any adjustment of confounders if there were differences in baseline characteristics (usually
demographics, but could be other variables) in groups. For the significant studies, only
Krauss [30] specified doing both an ITT and cross-over analysis, and thus, received “good”
ratings for confounding bias. Apinundecha [25], Klepp [28], and Krauss [30] received
“good” ratings for controlling for confounders; Apinundecha [25] and Krauss [30] through
their study design, and Klepp [28] through controlling for some confounders in their
statistical analysis.
Degree of measurement bias was rated based on whether or not a validated HIV/AIDS
stigma measurement—preferably a scale that measured different stigma constructs—was
used, and if the outcome assessors were blinded to the group assignment. None of the RCTs
reported having a blinded outcome assessor, and were given “poor” ratings for this indicator.
For the significant RCTs, only Apinundecha [25] and Krauss [30] used validated
instruments to measure perceived and enacted HIV/AIDS stigma, but Apinundecha’s [25]
instrument measured stigma in both HIV-infected and un-infected members of their study
population.
Lastly, 6 of the 9 RCTs [25,26,30,31,33] demonstrated appropriate statistical testing and
reported either effect sizes, or mean score/% differences with associated p-values (none of
them reported confidence intervals). Based on the internal validity factors, the interventions’
focus, and the statistics used and reported, Krauss [30], Apinundecha [25] and Wu [33]
received “good” overall quality ratings. Wu’s [33] non-significant stigma finding may have
been due to insufficient sample size or inadequate measures of stigma, rather than something
related to how they conducted their intervention trial.
Non-Randomized Studies’ Quality Ratings
Table 3 also presents the quality assessments for the non-randomized control group studies
and pretest–posttest one group studies. All of the six non-randomized control group studies
demonstrated significant results for their HIV/AIDS stigma outcome [24,34–38]. Only Yang
[24] had an intervention that solely focused on reducing HIV/AIDS stigma. For the four
pretest–posttest one group studies, only three [23,39,40] demonstrated significant results for
their HIV/AIDS stigma outcome, and two of these studies [27,28] had interventions with
one or more components focused on reducing HIV/AIDS stigma.
For the non-randomized control group studies, we gave them “poor” ratings for the
randomization indicators because they did not use randomization to assign participants to
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intervention and control groups. For the pretest–posttest one group studies, the
randomization indicators were not applicable.
Degree of selection bias for the non-randomized control group studies was based on the
same criteria as the RCTs, but only loss to follow-up was considered for the pretest–posttest
one group studies. For the non-randomized control group studies, only Fawole [34] had
“good” ratings for selection bias. For the pretest–posttest one group studies, only Zachariah
[22] received a “good” rating by demonstrating no loss to follow-up.
Degree of confounding bias only was rated based on if they identified potential confounders
(e.g., demographics), and controlled for these confounders in their statistical analyses. Only
Fawole’s [34] study adequately addressed confounders in their statistical analysis and was
given a “good” rating.
Degree of measurement bias for the non-randomized control group studies was based on the
same criteria as the RCTs, but for the pretest–posttest one group studies, only the use of an
un-validated HIV/AIDS stigma measurement was considered. For the non-randomized
control group studies, only Fawole [34] reported having the outcome assessors blinded to
exposure status of group, and was given a “good” rating for this indicator. All of the non-
randomized control group studies, however, were given “fair” or “poor” ratings related to
the stigma outcome measurement they used. Fawole [34], Kuhn [35], Lueveswanij [36],
Merakou [37], and Yang [24] used un-validated, originally developed instruments that
measured primarily attitudes toward PLWHA of un-infected study populations; in the case
of Fawole [34], Kuhn [35], Lueveswanij [36], and Merakou [37], between 1 and 4 items
constituted their stigma measurement. For the same reasons, we gave “fair” or “poor”
ratings for the stigma outcome measurements used to all of the pretest–posttest one group
studies.
Lastly, only Fawole [34] from the non-randomized control group studies, and Pisal [39]
from the pretest–posttest one group studies were given “good” ratings for demonstrating
appropriate statistical testing and reporting either effect sizes, or mean score/% differences
with associated p-values (none of them reported confidence intervals). Based on the internal
validity factors, the interventions’ focus, and statistics used and reported, only Fawole’s [34]
study had a “fair” overall quality rating. All of the pretest–posttest one group studies were
considered “poor.”
Discussion
This systematic review revisits the question on the availability of effective interventions to
reduce HIV/AIDS stigma given that HIV/AIDS stigma results in negative health outcomes
in both industrialized and developing contexts. Of the 19 studies reviewed, 14 demonstrated
effectiveness in reducing HIV/AIDS stigma [23–25,27–30,34–40]. We also assessed the
quality of these 19 studies by rating their internal validity, the extent to which their
interventions targeted stigma reduction, the HIV/AIDS stigma measures used, and the
statistics reported to demonstrate pre- and post-intervention changes in their HIV/ AIDS
stigma outcomes. We then applied an overall quality rating to each study. Only 2 of the 14
effective studies—Apinundecha [25] and Krauss [30]—were given overall “good” quality
ratings. Although not significant, Wu’s [33] RCT provider intervention in China also
received an overall “good” rating. The paucity of good quality studies within the last 20
years identified in this review reveals the current gaps in evidenced-based interventions to
reduce HIV/AIDS stigma. These gaps include (1) not enough interventions targeting HIV/
AIDS stigma, (2) using disparate and inadequate measures to evaluate HIV/AIDS stigma
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reduction, (3) whether statistically significant stigma reduction in these intervention trials
has public health significance, and (4) the lack of good quality (internally valid) studies.
Regarding the first gap, only three of the studies in this review—Apinundecha [25], Yang
[24], and Wu [33]—tested interventions that aimed to reduce HIV/AIDS stigma. This was
surprising given the vast literature on HIV/AIDS stigma’s negative impact on HIV
prevention and treatment efforts, and repeated recommendations by stigma experts to target
HIV/AIDS stigma in their interventions and programs [12,41]. Furthermore, Apinundecha’s
[25] and Wu’s [33] studies had all, or the majority of the intervention strategies
(information, skill building, counseling, and PLWHA testimonials) identified from Brown et
al.’s [16] review incorporated into their interventions. The combination of developing
interventions that focus on stigma reduction, and using more than one strategy to deliver the
interventions, may have greater impact to enhance participants’ understanding about the
effect of HIV/ AIDS stigma in HIV-infected and/or at-risk populations.
This review brings attention to a second gap relating to the disparate and/or inadequate
measures used to evaluate stigma reduction in HIV intervention trials. The measures used
are disparate because none of the 19 studies in this review used a common scale despite the
fact that a recently published systematic review identified 23 HIV/AIDS stigma instruments
that are evidenced-based and available to researchers [10]. Only the scale used by
Apinundecha [25] was identified in the aforementioned systematic review, and has been
widely used in other studies [10]. The measures used in the 19 studies reviewed also are
inadequate, based on their lack of internal and/or external validation, and their narrow focus
on assessing, primarily, perceived stigma in un-infected populations. Only nine of the
studies in this review used a previously or originally validated scale to measure HIV/AIDS
stigma [22,23,25,27–30,32,38], and of these studies, only Apinundecha [25] used a measure
that is a multi-item, externally validated scale that measures community-level perceived and
enacted stigma [42].
Along with measurement issues is a third gap associated with whether the intervention
studies that demonstrated statistical significance in reducing HIV/AIDS stigma have public
health significance. For public health significance, we would like to see whether a reduction
in HIV/AIDS stigma was associated with improved change in health outcomes, such as
increased HIV testing, increased access to or utilization of HIV treatment/care, improved
policy support for PLWHA, improved mental health outcomes and social support, and/or
reduced HIV-related symptoms [10]. None of the 14 statistically significant studies
examined the relationship between reducing HIV/AIDS stigma and any health outcomes
associated with HIV prevention and treatment. Krauss’s RCT [30], however, may have
demonstrated some public health relevance since the improved change in comfort level to
interact with PLWHA was twice as high in the intervention group versus the control or
crossover groups. For the statistically significant studies that did not use a validated scale,
and/or used one to a few items to measure one or more of the complex constructs of HIV/
AIDS stigma [34–37], the evidence of stigma reduction is generally less meaningful.
The last gap highlighted in this review relates to the methodological rigor of the intervention
trials themselves. Typically, sample size calculations would be performed and reported for
any study in which effects of a particular outcome are being measured. None of the 19
studies reported sample size calculations, and for the non-significant studies, the negative
findings could be a result of inadequate sample sizes. This is particularly the case with Wu’s
study, which seemed to have fairly good internal validity, an intervention that targeted
stigma reduction, and appropriate statistical testing, but its pre/post-intervention findings
were not significant [33]. It is unclear if the negative findings were a result of the poor
stigma measure that they used, or because of inadequate sample sizes. Second, while using
Sengupta et al. Page 9













an RCT study design—when conducted properly—has an inherent advantage to minimize
selection and confounding biases that can affect intervention trials, all nine of the RCT
studies reviewed did not use “good” methods of randomization and allocation concealment
when assigning individuals or communities to groups. A consequence of poor randomization
is dissimilar groups at baseline that 6 of the 9 RCTs exhibited, and were given fair to poor
ratings for this quality indicator [26–29,31,32]. Third, the most appropriate analytic
approach in RCTs would be intention-to-treat (ITT) to take into account participants who
were lost to follow-up to further minimize confounding bias. Only Krauss reported both ITT
and crossover analyses to account for parents who declined to participate in the intervention
[30]. Lastly, having an outcome assessor (e.g., statistician) who is blinded to the group—in
either RCTs or non-randomized control group designs—is helpful to reduce measurement
bias. None of the RCTs reported having an outcome assessor blinded to group assignment,
and only Fawole [34] of the six non-randomized group studies reported using a blinded
outcome assessor. Using other study designs besides an RCT to assess effectiveness in
reducing stigma is much more challenging, and this review demonstrates the overall poorer
quality of the other 10 studies that used non-randomized control group or pretest/posttest
one group study designs.
Like other qualitative reviews of intervention studies, this systematic review has its
limitations. The gold standard for reviewing intervention effectiveness is with a meta-
analysis that calculates a pooled effect size from RCTs. In this review, the stigma
instruments of the RCTs were too heterogeneous to combine in a meta-analysis. Thus, we
broadened our criteria to examine three different types of study designs typically used to
conduct public health/social science intervention trials, and used a checklist to rate the
overall quality of each of the studies adapted from AHRQ’s Methods Guide for Comparative
Effectiveness [21] that satisfies PRISMA guidelines for conducting systematic reviews [18].
To address the gaps identified in this review, we have several recommendations that may
help guide researchers and organizations to develop studies in the future that better
determine whether interventions are effective or not in reducing HIV/AIDS stigma. First,
interventions that are not focused on reducing stigma, but that demonstrate a reduction in
HIV/AIDS stigma assessed with one or a few items, is inadequate. Designing stigma
reduction interventions should include formative research to understand the issues of HIV/
AIDS stigma affecting a particular target population, and using the formative data to
develop intervention components that target the issues of HIV/AIDS stigma identified.
Second, when considering which instrument to use to measure changes in HIV/AIDS
stigma, it is important to choose an instrument that has undergone internal validation (e.g.,
psychometric analysis), and possibly external validation of its items; these instruments will
more likely be measuring more than one concept (i.e., perceived, enacted, internalized, or
compounded stigma). Third, researchers should consider using RCT study designs, if
possible, to conduct their intervention trials, paying attention to issues pertaining to internal
validity. Lastly, even with a well-designed intervention that demonstrates a reduction in
HIV/AIDS stigma, we currently know very little about how or if the change in stigma
reduction affects associated health outcomes, such as increasing HIV testing, increasing
access to HIV treatment/ care, improving policy support for PLWHA, improving mental
health outcomes and social support, and/or reducing HIV-related symptoms [10]. Thus,
future research on the effectiveness of HIV/AIDS stigma reduction interventions must
additionally measure health outcomes of interest, pre-/post-intervention, to understand and
appreciate the need for HIV/AIDS stigma reduction globally.
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In conclusion, updating our current knowledge about interventions to reduce HIV/AIDS
stigma is an important step in understanding the breadth of HIV/AIDS stigma reduction
efforts currently available. Of the 19 studies reviewed, only three RCTs (two significant and
one not significant) were considered of higher quality, and that we would recommend to be
replicated in similar and other cultural contexts [25,30,33]. More importantly, we hope that
our recommendations to guide future intervention studies targeting HIV/AIDS stigma
reduction will be useful to researchers and organizations dedicated to this work.
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Table 1
Study and intervention characteristics of the 19 studies
1st Author, publication date Study population Baseline sample size Intervention strategiesa
Country # Arms Intervention duration
RCTs
 Apinundecha [25], 2008 Community 66 I, SB, CS, T
 Thailand 2 8 months
 Ashworth [26], 1994 Women in WIC program 217 I
 United States 3 15–18 min
 Gill [27], 1993 Students (6th grade) 257 I
 Canada 2 200 min
 Klepp [28], 1997 Students (6th grade) 1,063 I
 Tanzania 2 20 h
 Knaus [29], 1999 Students (College) 416 I
 United States 2 1-time attending quilt display
 Krauss [30], 2006 Parents and pre-adolescent children 238 I
 United States 3 12 h
 Markham [31], 2000 Students (High school) 1,491 I, SB, T
 United States 2 2 years
 Stewart [32], 1999 Providers (Nurses) 88 I
 United Kingdom 2 90 min
 Wu [33], 2008 Providers 138 I, SB, T
 China 2 4 h
Non-randomized control group studies
 Fawole [34], 1999 Students (High school) 450 I, SB
 Nigeria 2 6 weeks
 Kuhn [35], 1994 Students (High school) 567 I
 South Africa 2 2 weeks
 Lueveswanij [36], 2000 Providers (Oral health) 139 I, SB, T
 Thailand 2 3 days
 Merakou [37], 2006 Students (High school) 702 I
 Greece 2 1 year
 Norr [38], 2004 Working women 403 I
 Botswana 2 6, 90-min sessions
 Yang [24], 2004 Community 490b I, CS
 China 1b 1 year
Pretest/posttest one group studies
 Pisal [39], 2007 Providers (Nurses) 371 I, SB, CS, T
 India 1 4 days
 Rounds [23], 1995 PLWHA 18 I, CS
 United States 1 6 h, 1 h/week
 Sowell [40], 1998 Providers (Nurses) 173 I
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1st Author, publication date Study population Baseline sample size Intervention strategiesa
Country # Arms Intervention duration
 United States 1 3 years
 Zachariah [22], 1998 Providers (Nurses) 35 I
 United States 1 1 h
a
Brown et al.’s [25] classification of types of intervention strategies: informational approaches (I), skill building (SB), counseling/support (CS),
and PLWHA testimonials (T)
b
For the Yang [24] study, a non-randomized control group study design was reported, but the baseline sample size (and subsequent findings) only
was reported for the intervention group
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Table 2







# Items Types of
stigmab
Results or NSc Interpretation



















Chi-square, 11/12 items, P < .
01
5–20% increase in “yes”
responses after intervention;
no data reported for control
group
Increase in “yes” responses







Mixed effects models: NS No group differences on
agreement/ item = no
differences in stigma


















Mixed Model ANOVA, P = .
0015
Effect size = 2.8













Children’s total comfort in
interacting with PLWHA




















model: NS for effect of overall
intervention
Unsure what NS means since




HIV− Validated (4 of 6 items)
6-item scale
PS




Intervention group had more
positive attitudes toward







Paired t-tests/item, P <.0001:
score differences range from
9.4–57.5








Reported pre/post item results
as significant, but no test
statistic/p- values:
improvement ranged from 2 to
23%
Pre/post improvement in
attitudes toward caring for
PLWHA

















Intervention group had more %
agreement on if they could
touch and care for PLWHA at
post-intervention




















# Items Types of
stigmab




8-item index (6 items on
stigma)
PS




Intervention group had more
positive attitudes toward







Test statistic not reported, 1




accept PLWHA student into









Intervention: 9%, P = .006
Control: 16%, .0005
Intervention group had lower
agreement that HIV carriers









score difference P < .05: 1.78
Decreased feelings of being


















No intervention effect on
AIDS phobia or homophobia
a
For study designs, “Nonrandom grp.” is abbreviated for pre-test/post-test with non-randomized control group; “One group” is abbreviated for pre-
test/post-test one group (no control group)
b
Types of stigma measured in the 19 studies are either perceived stigma and/or enacted stigma. Perceived stigma is abbreviated as “PS”; enacted
stigma is abbreviated as “ES.”
c
“NS” stands for non-significant results at threshold of .05 for the stigma measure
d
For Fawole’s [34] study, findings of the stigma item and one other (non-stigma) attitude item were combined to create an overall attitudinal score
(not shown)
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